Pure Global
NCT06305377

Achieving Rapid, Safe and Sustained Glucose Control in Adolescents With Suboptimally Controlled Type 1 Diabetes Using Advanced Hybrid Closed Loop Systems

Turning the Tides: Achieving Rapid, Safe and Sustained Glucose Control in Adolescents With Suboptimally Controlled Type 1 Diabetes Using Advanced Hybrid Closed Loop Systems
Giulio Frontino·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus, Type 1
Drug/Device/Intervention
Tandem Control IQ
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Giulio Frontino
Funder
IRCCS San Raffaele
Timeline & enrollment
Phase
N/A
Start date
Mar 11, 2024
End date
Mar 30, 2024
Enrollment
20 participants
Primary outcome

Glucometric data

Summary

The rational of this study is to assess if AHCL systems are able to achieve a better
 metabolic control (better glucometric data) after 2 weeks, 1 months. 6 months and 1 year
 after the start, in adolescents in not good glycaemic control.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06305377
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06305377 through Pure Global AI's free database. This phase not specified trial is sponsored by Giulio Frontino and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.